|
|
|
Volumn 299, Issue 5613, 2003, Pages 1638-1639
|
|
Judge turns Rochester's golden patent into lead
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOOXYGENASE 2;
ISOENZYME;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
BLEEDING;
CANCER RESEARCH;
DECISION MAKING;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
GENETIC ENGINEERING;
HUMAN;
LAW;
MOLECULAR CLONING;
NOTE;
PAIN;
PATENT;
PRIORITY JOURNAL;
SIDE EFFECT;
STOMACH HEMORRHAGE;
ARTICLE;
DRUG ANTAGONISM;
GENETICS;
LEGAL ASPECT;
UNITED STATES;
UNIVERSITY;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CLONING, MOLECULAR;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG INDUSTRY;
ISOENZYMES;
NEW YORK;
PATENTS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
SULFONAMIDES;
UNITED STATES;
UNIVERSITIES;
|
|
EID: 0037436462
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|